Treatment of Bullous Impetigo
Recommended Antibiotic Type and Duration
For bullous impetigo, use oral cephalexin 25-50 mg/kg/day divided into 4 doses (or dicloxacillin at the same dosing) for 7 days as first-line therapy, switching to clindamycin or trimethoprim-sulfamethoxazole if MRSA is suspected. 1
Antibiotic Selection Algorithm
First-Line Therapy for Presumed MSSA
- Cephalexin is the preferred first-line oral antibiotic at 25-50 mg/kg/day divided into 4 doses for 7 days 1
- Dicloxacillin is an equally effective alternative at 25-50 mg/kg/day divided into 4 doses for 7 days 1
- Both agents demonstrated equal efficacy in treating staphylococcal bullous impetigo, with prompt clearing of lesions within the first week 2
MRSA Coverage When Indicated
- Clindamycin 20-30 mg/kg/day divided into 3 doses for 7 days should be used when MRSA is suspected or confirmed 1, 3
- Trimethoprim-sulfamethoxazole (SMX-TMP) 8-12 mg/kg/day (based on trimethoprim component) divided into 2 doses for 7 days is an alternative MRSA-covering option 1
- Doxycycline 2-4 mg/kg/day divided into 2 doses for 7 days can be used in children over 8 years old when MRSA is suspected 1
Alternative Oral Options
- Co-amoxiclav (amoxicillin-clavulanic acid) for 7 days is an acceptable alternative that covers both S. aureus and S. pyogenes 1
- This is particularly useful when dicloxacillin or cephalexin are not suitable 1
Critical Duration Point
The standard duration for oral antibiotic therapy is 7 days, not the shorter 5-day course used for topical agents. 1, 3
Important Clinical Considerations
Why Bullous Impetigo Requires Specific Therapy
- Bullous impetigo is exclusively caused by toxin-producing Staphylococcus aureus, unlike non-bullous impetigo which may involve Streptococcus pyogenes 1
- This makes anti-staphylococcal coverage essential 4
Antibiotics to Avoid
- Penicillin alone is seldom effective for impetigo and should only be used when cultures confirm streptococci alone 1
- Amoxicillin alone should not be used because it lacks adequate coverage against S. aureus 1
- Only 2 of 64 staphylococcal strains in one study were susceptible to penicillin G 2
When to Consider MRSA Coverage
- In areas with high MRSA prevalence, empiric therapy should cover MRSA until culture results are available 1
- Consider obtaining cultures if there is treatment failure, MRSA is suspected, or in cases of recurrent infections 3
Special Population Considerations
Pediatric Patients
- Tetracyclines (doxycycline) should be avoided in children under 8 years due to the risk of dental staining 1, 3
Pregnant Patients
Penicillin-Allergic Patients
- Clindamycin or macrolides can be used, though resistance rates to erythromycin are rising 1
- Avoid cephalosporins if type 1 hypersensitivity (anaphylaxis/hives) to β-lactams exists 3
Common Pitfalls to Avoid
- Do not use topical therapy alone for bullous impetigo with large bullae or extensive disease—oral antibiotics are required 4
- Do not assume 5 days is sufficient—the standard oral antibiotic duration is 7 days, not 5 1, 3
- Reassess by 3-5 days if no improvement occurs, considering MRSA infection, deeper infection, non-compliance, or antibiotic resistance 3